What is Blake Zelickson's NPI number?

Blake Zelickson's National Provider Identifier (NPI) is 1902292394, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Blake Zelickson's specialty?

Blake Zelickson is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Blake Zelickson located?

Blake Zelickson's practice location on file with NPPES is 22365 Broderick Drive, Suite 115, Sterling, VA 20166-9362.

What is Blake Zelickson's phone number?

The practice phone number listed in the NPPES registry for Blake Zelickson is (170) 399-6400.

Does Blake Zelickson accept Medicare?

Blake Zelickson is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Blake Zelickson's NPI active?

Yes — Blake Zelickson's NPI (1902292394) is active in the NPPES registry as of the last update on 2026-01-05.

IndividualActiveAccepts Medicare

Blake Zelickson, M.D., PH.D.

NPI 1902292394 · Dermatology Physician · Sterling, VA

Blake Zelickson, M.D., PH.D. is a Dermatology Physician provider in Sterling, VA (NPI 1902292394).

Provider details

NPI number: 1902292394
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: M.D., PH.D.
Sex: Male
Sole proprietor: Yes
License: 0101269123 (VA)

Practice location

22365 Broderick Drive, Suite 115

Sterling, VA 20166-9362

Phone: (170) 399-6400

Fax: (571) 707-8123

Street-level locationGet directions

More VA providers

Mailing address

22365 Broderick Dr Ste 115

Sterling, VA 20166-9362

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 0101269123 (VA)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(61/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
11 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
722 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	178	$87
Destruction of Precancer Skin Growth, 2-14 Growths17003	131	$7
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	101	$125
Biopsy of Related Skin Growth, First Growth11102	93	$96
New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More99203	72	$108
New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 14 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Clobetasol Propionate	88	45
Triamcinolone Acetonide	48	34
Ketoconazole	36	17
Minoxidil	27	—
Dutasteride	26	—
Hydrocortisone	21	16
Montelukast Sodium	20	—
Dupilumabbrand: Dupixent Pen

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$1,150 across 27 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2015-04-13
Last updated: 2026-01-05
Certified: 2026-01-05

Frequently asked questions

What is Blake Zelickson's NPI number?: Blake Zelickson's National Provider Identifier (NPI) is 1902292394, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Blake Zelickson's specialty?: Blake Zelickson is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Blake Zelickson located?: Blake Zelickson's practice location on file with NPPES is 22365 Broderick Drive, Suite 115, Sterling, VA 20166-9362.
What is Blake Zelickson's phone number?: The practice phone number listed in the NPPES registry for Blake Zelickson is (170) 399-6400.
Does Blake Zelickson accept Medicare?: Blake Zelickson is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Blake Zelickson's NPI active?: Yes — Blake Zelickson's NPI (1902292394) is active in the NPPES registry as of the last update on 2026-01-05.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	178	$87
Destruction of Precancer Skin Growth, 2-14 Growths17003	131	$7
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	101	$125
Biopsy of Related Skin Growth, First Growth11102	93	$96
New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More99203	72	$108
New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More

Drug

Part D claims (2024)

Beneficiaries

Clobetasol Propionate

Triamcinolone Acetonide

Ketoconazole

Minoxidil

—

Dutasteride

—

Hydrocortisone

Montelukast Sodium

—

Dupilumabbrand: Dupixent Pen

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$1,150 across 27 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments